Merck and Japan-based Daiichi Sankyo have withdrawn their U.S. application for an experimental lung cancer treatment after it ...

NHS England has announced the roll-out of a new liquid biopsy blood test to help lung cancer patients receive targeted ...

A new targeted cancer drug, DB-1310, is showing early signs of effectiveness in patients with advanced solid tumors that have ...

Radiation therapy can treat lung cancer at all stages, easing symptoms, improving precision and minimizing side effects with ...

Rapid advances in cancer treatment have benefited many people, but urgent change is needed in Canada's cancer care workforce ...

Researchers from The University of Texas MD Anderson Cancer Center have identified a new biomarker, TTF-1, that was ...

England has rolled out a new liquid biopsy test intended to fast-track lung cancer patients to receive targeted therapy.

Discover seven lung cancer companies advancing promising candidates through the clinic, from viral immunotherapies to ...

Tens of thousands of patients could benefit from liquid biopsies, which give results up to two weeks faster than tissue ...

Announcing the rollout on the eve of the world’s largest cancer conference, which will take place in Chicago from Friday, NHS ...

Genetic testing for hereditary cancer unexpectedly uncovered a case of myelodysplastic syndrome (MDS), highlighting the need ...